ASCENTAGE PHARMA GROUP INTERNATIONAL

Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.

AAPG | US

Overview

Corporate Details

ISIN(s):: US04390B1052
LEI:
Country:: United States of America
Address:: 68 XINQING ROAD, 0 SUZHOU , JIANGSU
Website:: https://www.ascentage.cn/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ascentage Pharma Group International is a global, clinical-stage biopharmaceutical company focused on developing novel therapies for cancers, chronic hepatitis B, and age-related diseases with unmet medical needs. The company's core R&D strategy targets apoptosis pathways, specializing in small-molecule drug candidates that inhibit protein-protein interactions. Its robust pipeline features potential first-in-class and best-in-class assets, including the approved third-generation BCR-ABL inhibitor olverembatinib and the Bcl-2 inhibitor lisaftoclax. With over 40 clinical trials active globally, Ascentage Pharma has secured numerous priority and orphan drug designations from the US FDA and China's CDE. The company actively pursues a global strategy through clinical and commercial collaborations with leading pharmaceutical companies and research institutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ASCENTAGE PHARMA GROUP INTERNATIONAL filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ASCENTAGE PHARMA GROUP INTERNATIONAL

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ASCENTAGE PHARMA GROUP INTERNATIONAL via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Magle Chemoswed Holding AB A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.	Sweden	MAGLE
Mainz BioMed N.V. Develops at-home diagnostic tests for the early detection of life-threatening cancers.	Germany	MYNZ
MANNKIND CORP Develops inhaled therapies for endocrine, orphan lung, and cardiometabolic diseases.	United States of America	MNKD
MARAVAI LIFESCIENCES HOLDINGS, INC. Provides nucleic acid products and biologics safety testing for new therapies and vaccines.	United States of America	MRVI
Marinomed Biotech AG Develops virus-blocking products & immunology therapies via proprietary technology platforms.	Austria	MARI
Marker Therapeutics, Inc. Developing non-genetically modified T cell immunotherapies for hematologic and solid tumors.	United States of America	MRKR
Matinas BioPharma Holdings, Inc. Developing oral drugs via a lipid nano-crystal platform for infections, oncology & inflammation.	United States of America	MTNB
Matricelf Ltd. Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.	Israel	MTLF
Maze Therapeutics, Inc. Develops genetic precision medicines for common diseases, with a focus on chronic kidney disease.	United States of America	MAZE
MBX Biosciences, Inc. Developing novel peptide therapies for underserved endocrine and metabolic disorders.	United States of America	MBX